Veraxa Auditor BDO Resigns; KPMG Proposed at 10 December EGM
VRXA is trading near its 52-week low of $0.9 (14% above the low).
Summary
BDO AG has resigned as Veraxa's auditor, and the board wants shareholders to elect KPMG AG for 2026 at an extraordinary meeting on 10 December 2026. No reason for the resignation is given in the filing.
Key Events · Corporate Governance and Compliance · VRXA
-
Auditor BDO Resigns
BDO AG, Baden, has announced its resignation as Veraxa's statutory auditor; the filing does not state a reason.
-
KPMG Proposed as Replacement
The board proposes electing KPMG AG, Zurich, as statutory auditor for the 2026 business year.
-
EGM Set for 10 December 2026
The Extraordinary General Meeting will be held on 10 December 2026 at 11:00 AM in Zurich, with a record date of 13 November 2026. Auditor election is the sole agenda item.
-
Reporting Assurance Gap
Until a successor auditor is elected and engaged, assurance over 2026 financial reporting is interrupted — a governance concern for a post-de-SPAC issuer.
Analysis · VRXA · Life Sciences
An unplanned auditor departure is a governance red flag, and Veraxa's statutory auditor BDO AG has resigned without the filing stating a reason. The board is asking shareholders to elect KPMG AG for the 2026 business year at an extraordinary meeting on 10 December 2026. Such departures can reflect disagreement over accounting, controls or disclosure. Until KPMG is elected and completes its work, investors have less assurance over the company's financial reporting — a real concern for a recently de-SPACed company that already carries a $27.5M secured note and a $50M ATM program. The vote is the next concrete checkpoint.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VRXA was trading at $1.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $152.2M. The 52-week trading range was $0.90 to $27.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.